Paxlovid Is Effective but Underused—Here’s What the Latest Research Says About Rebound and More
Rita Rubin
Abstract
This Medical News story examines the latest information about rebound, treatment eligibility, optimal dosing, and other questions related to nirmatrelvir-ritonavir for treating COVID-19.
Topics & Concepts
MedicineDosingCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakDrug approvalMEDLINEIntensive care medicineMedical emergencyFamily medicineVirologyPharmacologyLawDrugInternal medicineDiseaseInfectious disease (medical specialty)OutbreakPolitical scienceInfectious Encephalopathies and Encephalitis